Clinical Trials Browser

Withdrawn × Lung Neoplasms × Trabectedin × Clear all

NCT03496519 2018-10-09

Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors

Phase 1 Withdrawn

SarcomaThoracic

Lung Neoplasms, Sarcoma